Google Health licenses its AI breast cancer screening tool

Summary by Ground News

Medical technology iCAD Inc. announced on Monday it has signed a commercialization agreement with Google Health to utilize its artificial intelligence technology for the improvement of breast cancer screenings.

Published 4 months ago · Mountain View, United States

News Articles

More Filters

All

Left

Center

Right

The Hill

Medical tech company partners with Google to improve breast cancer screenings

Medical technology company iCAD Inc. announced on Monday it has signed a commercialization agreement with Google Health to utilize its artificial intelligence (AI) technology for the improvement of breast cancer screenings. In a statement, iCAD said Google will be licensing its AI tech for “breast cancer and personalized risk assessment.” This marks the first instance…

4 months ago·Washington, United States

Read Full Article

Business Standard

Google to develop AI with iCAD to improve breast cancer screening

This will be Google's first commercial agreement to license its mammography AI research model to be integrated into real-world clinical practice

4 months ago·India

Read Full Article

The Verge

Google partners with med tech company to develop AI breast cancer screening tools

In a first, Google licensed its mammography AI research model to medical technology company iCAD. Together, the companies hope to improve cancer detection and risk assessment tools.

4 months ago·United States

Read Full Article

theregister.com

Google Health licenses its AI breast cancer screening tool

iCAD will have five years to bring a product to market

4 months ago

Read Full Article

interestingengineering.com

Google licenses its AI tool for breast cancer screening to a medical firm

It is the first ever commercial partnership between Google Health and the medical company iCAD.

4 months ago

Read Full Article

Neowin

Google partners with iCAD to improve breast cancer screening through AI

The new partnership with iCAD makes for Google's first commercial agreement to license its AI-based mammography model and eventually integrate it with real-world clinical products.

4 months ago

Read Full Article